News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
637,143 Results
Type
Article (55515)
Company Profile (72)
Press Release (581556)
Section
Business (173409)
Career Advice (2702)
Deals (32494)
Drug Delivery (98)
Drug Development (76028)
Employer Resources (155)
FDA (14861)
Job Trends (13880)
News (304014)
Policy (29074)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 Pharm Country Premier (1)
Academia (2684)
Academic (2)
Accelerated approval (5)
Adcomms (24)
Allergies (82)
Alliances (43359)
ALS (80)
Alzheimer's disease (1283)
Antibody-drug conjugate (ADC) (97)
Approvals (14871)
Artificial intelligence (243)
Autoimmune disease (18)
Automation (13)
Bankruptcy (293)
Best Places to Work (10867)
BIOSECURE Act (19)
Biosimilars (98)
Biotechnology (47)
Bladder cancer (61)
Brain cancer (26)
Breast cancer (249)
Cancer (1956)
Cardiovascular disease (150)
Career advice (2284)
Career pathing (32)
CAR-T (147)
Cell therapy (406)
Cervical cancer (20)
Clinical research (61713)
Collaboration (737)
Compensation (279)
Complete response letters (20)
COVID-19 (2510)
CRISPR (38)
C-suite (228)
Cystic fibrosis (99)
Data (1919)
Decentralized trials (1)
Denatured (25)
Depression (40)
Diabetes (229)
Diagnostics (6135)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (108)
Drug pricing (98)
Drug shortages (23)
Duchenne muscular dystrophy (76)
Earnings (60225)
Editorial (34)
Employer branding (19)
Employer resources (135)
Events (94436)
Executive appointments (677)
FDA (15977)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (683)
Gene editing (99)
Generative AI (20)
Gene therapy (266)
GLP-1 (628)
Government (4464)
Grass and pollen (5)
Guidances (46)
Healthcare (18180)
Huntington's disease (18)
IgA nephropathy (19)
Immunology and inflammation (97)
Indications (25)
Infectious disease (2634)
Inflammatory bowel disease (131)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (86)
Interviews (521)
IPO (14850)
IRA (41)
Job creations (3404)
Job search strategy (1920)
Kidney cancer (9)
Labor market (27)
Layoffs (491)
Leadership (17)
Legal (6432)
Liver cancer (65)
Lung cancer (282)
Lymphoma (125)
Machine learning (4)
Management (53)
Manufacturing (246)
MASH (55)
Medical device (12499)
Medtech (12503)
Mergers & acquisitions (18155)
Metabolic disorders (574)
Multiple sclerosis (70)
NASH (15)
Neurodegenerative disease (74)
Neuropsychiatric disorders (24)
Neuroscience (1747)
NextGen: Class of 2025 (6349)
Non-profit (4338)
Northern California (2193)
Now hiring (15)
Obesity (297)
Opinion (236)
Ovarian cancer (71)
Pain (82)
Pancreatic cancer (72)
Parkinson's disease (129)
Partnered (20)
Patents (204)
Patient recruitment (99)
Peanut (49)
People (58446)
Pharmaceutical (22)
Pharmacy benefit managers (15)
Phase I (19483)
Phase II (27296)
Phase III (19882)
Pipeline (1001)
Podcasts (54)
Policy (110)
Postmarket research (2356)
Preclinical (8135)
Press Release (64)
Prostate cancer (93)
Psychedelics (30)
Radiopharmaceuticals (249)
Rare diseases (341)
Real estate (5955)
Recruiting (63)
Regulatory (20095)
Reports (33)
Research institute (2470)
Resumes & cover letters (404)
Rett syndrome (4)
RNA editing (3)
RSV (33)
Schizophrenia (62)
Series A (122)
Series B (78)
Service/supplier (9)
Sickle cell disease (50)
Southern California (1950)
Special edition (10)
Spinal muscular atrophy (147)
Sponsored (26)
Startups (3324)
State (1)
Stomach cancer (9)
Supply chain (50)
Tariffs (6)
The Weekly (27)
United States (19529)
Vaccines (638)
Venture capitalists (31)
Webinars (11)
Weight loss (188)
Women's health (30)
Worklife (19)
Date
Today (89)
Last 7 days (686)
Last 30 days (2559)
Last 365 days (31044)
2025 (7786)
2024 (32324)
2023 (36423)
2022 (46728)
2021 (51651)
2020 (50668)
2019 (44640)
2018 (34001)
2017 (30525)
2016 (29826)
2015 (35156)
2014 (28164)
2013 (24498)
2012 (25746)
2011 (25973)
2010 (24384)
Location
Africa (863)
Alabama (51)
Alaska (7)
Arizona (161)
Arkansas (13)
Asia (37396)
Australia (6735)
California (5028)
Canada (1708)
China (437)
Colorado (232)
Connecticut (242)
Delaware (121)
Europe (86543)
Florida (770)
Georgia (187)
Idaho (55)
Illinois (504)
India (24)
Indiana (265)
Iowa (7)
Japan (128)
Kansas (93)
Kentucky (23)
Louisiana (8)
Maine (59)
Maryland (776)
Massachusetts (3680)
Michigan (208)
Minnesota (321)
Mississippi (2)
Missouri (83)
Montana (30)
Nebraska (22)
Nevada (51)
New Hampshire (60)
New Jersey (1506)
New Mexico (29)
New York (1487)
North Carolina (896)
North Dakota (7)
Northern California (2193)
Ohio (182)
Oklahoma (15)
Oregon (34)
Pennsylvania (1127)
Puerto Rico (9)
Rhode Island (22)
South America (1168)
South Carolina (16)
South Dakota (1)
Southern California (1950)
Tennessee (88)
Texas (779)
Utah (156)
Virginia (125)
Washington D.C. (52)
Washington State (474)
West Virginia (3)
Wisconsin (52)
637,143 Results for "institute of psychiatry".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics
January 2, 2025
·
8 min read
Press Releases
ORYZON Announces Journal Publication of Final Phase IIa REIMAGINE Results with Vafidemstat in Psychiatry and Clinical Neurosciences
February 17, 2025
·
8 min read
Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
Alkermes plc announced the presentation of research related to its psychiatry franchise products—LYBALVI® and ARISTADA® —at four scientific conferences this spring.
May 14, 2024
·
20 min read
Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry
Relmada Therapeutics, Inc. today announced the publication of REL-1017 clinical data from the Reliance I Study in the peer-reviewed journal, The Journal of Clinical Psychiatry.
June 18, 2024
·
5 min read
Press Releases
Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy
April 1, 2025
·
7 min read
Biotech Bay
UCSF QBI and the Department of Psychiatry and Behavioral Sciences Announce Breakthrough Research Findings in the Molecular Understanding of Autism
The Quantitative Biosciences Institute, in collaboration with the Department of Psychiatry and Behavioral Sciences, at the University of California, San Francisco, reported new breakthrough research findings in the understanding of autism spectrum disorder.
December 4, 2023
·
5 min read
GLP-1
Novo’s Semaglutide Shows Promise for Alcohol Use Disorder
The data, published in
JAMA Psychiatry
, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for addictive disorders.
February 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Adams Clinical Announces Expansion into Inpatient Psychiatry and Schizophrenia Clinical Trial Capabilities with Signing of Partnership with InSite Clinical Research
December 11, 2024
·
4 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announce Dura Medical as the Expected Initial Florida Acquisition for its Planned International Network of Interventional Psychiatry Clinics
January 6, 2025
·
6 min read
1 of 63,715
Next
